News Website

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer BioSpace

Published: June 9, 2025, 12:43 p.m.

Read Full Article

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:18 p.m.

Read Full Article

Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News - Stock Titan

Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News Stock Titan

Published: June 9, 2025, noon

Read Full Article

Women Health: 7 sience backed facts about PCOS and Endometriosis every woman should know - Asianet Newsable

Women Health: 7 sience backed facts about PCOS and Endometriosis every woman should know Asianet Newsable

Published: June 7, 2025, 1:35 p.m.

Read Full Article

Sarah became lactose intolerant at 22. She knew it was a deadly sign. - Mamamia

Sarah became lactose intolerant at 22. She knew it was a deadly sign. Mamamia

Published: June 6, 2025, 10:59 p.m.

Read Full Article

Alicia Latham, MD, MS, on Using ctDNA to Detect Endometrial Cancer - The ASCO Post

Alicia Latham, MD, MS, on Using ctDNA to Detect Endometrial Cancer The ASCO Post

Published: June 6, 2025, 5:43 p.m.

Read Full Article

From Endometriosis to Asherman’s: Ob/Gyn Chair Tackles the Toughest Cases - Yale Medicine

From Endometriosis to Asherman’s: Ob/Gyn Chair Tackles the Toughest Cases Yale Medicine

Published: June 6, 2025, 5:05 p.m.

Read Full Article

Study Links Early-Stage Endometriosis to Fourfold Increase in Sarcopenia Risk - Medical Dialogues

Study Links Early-Stage Endometriosis to Fourfold Increase in Sarcopenia Risk Medical Dialogues

Published: June 6, 2025, 3:30 p.m.

Read Full Article

Bindi Irwin Sought Help and Now Has a Plea to Other Women After Emergency Surgery - MSN

Bindi Irwin Sought Help and Now Has a Plea to Other Women After Emergency Surgery MSN

Published: June 6, 2025, 1 p.m.

Read Full Article

Alex Marquardt’s CNN Exit Follows Fallout From Defamation Case - MSN

Alex Marquardt’s CNN Exit Follows Fallout From Defamation Case MSN

Published: June 5, 2025, 11:36 p.m.

Read Full Article

Latest Articles

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer | AZN Stock News - GuruFocus

Phase 3 Trial Launches ENHERTU as First-Line Endometrial Cancer Treatment | CGEN Stock News - Stock Titan

Women Health: 7 sience backed facts about PCOS and Endometriosis every woman should know - Asianet Newsable

Sarah became lactose intolerant at 22. She knew it was a deadly sign. - Mamamia

Alicia Latham, MD, MS, on Using ctDNA to Detect Endometrial Cancer - The ASCO Post

From Endometriosis to Asherman’s: Ob/Gyn Chair Tackles the Toughest Cases - Yale Medicine

Study Links Early-Stage Endometriosis to Fourfold Increase in Sarcopenia Risk - Medical Dialogues

Bindi Irwin Sought Help and Now Has a Plea to Other Women After Emergency Surgery - MSN

Alex Marquardt’s CNN Exit Follows Fallout From Defamation Case - MSN

Subscribe to Our Newsletter